Product Reports Resources Pricing Login Book a demo

Ophelia

Biotech & Life Sciences · New York City, United States · Founded 1994

Medication and support for opioid withdrawal, in the privacy of home MoreLess

Ophelia is a healthcare startup focused on providing medication-assisted treatment (MAT) for individuals struggling with opioid dependence. The company operates in the healthcare sector, specifically targeting patients who are experiencing cravings or withdrawal symptoms related to opioid use. Ophelia's business model revolves around offering scientifically-backed treatments that replace traditional rehab methods with a more modern, private, and convenient approach. The company makes money by providing these medical services directly to patients, leveraging a team of doctors, scientists, and tech experts to deliver high-quality care. Ophelia's mission is to eliminate the stigma associated with drug rehab by offering a discreet and effective alternative that empowers patients to make their own choices. The company serves a diverse clientele, primarily focusing on individuals under the age of 50, who are at the highest risk of opioid overdose. By combining medical expertise with a patient-centric approach, Ophelia aims to revolutionize the way opioid dependence is treated in the United States.

Keywords: opioid dependence, medication-assisted treatment, healthcare startup, opioid cravings, withdrawal symptoms, patient-centric, privacy, convenience, scientific treatment, modern rehab.

Valuation $250–500M
Revenue $10–50M
Headcount 100–500
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Ophelia and the history behind them.

Talent graph

Ophelia's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

13 investors on Ophelia's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Series A 10 investors entered at this stage
Menlo Ventures
Bloom Institute of Technology
Warby Parker
Harry's
PillPack
Smartbird | formerly Allbirds
Carbon Health
Tiger Global
Interplay
640 Oxford Ventures

Global footprint

Where Ophelia has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States98.3%
🇲🇦 Morocco0.8%
🇬🇧 United Kingdom0.8%
3 countries shown

Market sentiment

What the market is saying about Ophelia

An AI-synthesized read of the highest-engagement posts about Ophelia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ophelia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.